KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for LifeMD (LFMD) over the last 6 years, with Q3 2025 value amounting to -$1.2 million.

  • LifeMD's Other Non Operating Income changed N/A to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year change of. This contributed to the annual value of -$325198.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, LifeMD's Other Non Operating Income stood at -$1.2 million.
  • In the past 5 years, LifeMD's Other Non Operating Income registered a high of $184914.0 during Q1 2021, and its lowest value of -$1.8 million during Q3 2021.
  • Over the past 4 years, LifeMD's median Other Non Operating Income value was -$901910.0 (recorded in 2021), while the average stood at -$759699.1.
  • As far as peak fluctuations go, LifeMD's Other Non Operating Income crashed by 52686.43% in 2021, and later surged by 10702.95% in 2022.
  • Quarter analysis of 4 years shows LifeMD's Other Non Operating Income stood at -$1.3 million in 2021, then skyrocketed by 104.82% to $63400.0 in 2022, then crashed by 612.93% to -$325198.0 in 2023, then tumbled by 269.01% to -$1.2 million in 2025.
  • Its Other Non Operating Income was -$1.2 million in Q3 2025, compared to -$325198.0 in Q1 2023 and $63400.0 in Q2 2022.